William D. Humphries - 19 May 2023 Form 4 Insider Report for PhaseBio Pharmaceuticals Inc

Role: Director
Signature: /s/ Jonathan P. Mow, Attorney-in-fact
Issuer symbol: N/A
Transactions as of: 19 May 2023
Net transactions value: $0
Form type: 4
Filing time: 19 May 2023, 16:18:07 UTC
Previous filing: 24 Jun 2022
Next filing: 05 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	PHASQ	Common Stock	Options Exercise		+2,538			2,538	19 May 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	PHASQ	Restricted Stock Units	Options Exercise	$0	-2,538	-100%	$0.000000^*	0	19 May 2023	Common Stock	2,538		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each Restricted Stock Unit ("RSU") represents a contingent right to receive one share of PhaseBio Pharmaceuticals, Inc. common stock.
F2	The RSUs vested and were delivered to the Reporting Person on the one-year anniversary of the grant date, subject to the Reporting Person's continuous service through such date.